Activity of fractionated radioimmunotherapy with clivatuzumab tetraxetan combined with low-dose gemcitabine (Gem) in advanced pancreatic cancer (APC) Meeting Abstract

cited authors

  • Ocean, A. J.; Guarino, M. J.; Pennington, K. L.; Montero, A. J.; Bekaii-Saab, T.; Gulec, S. A.; Teoh, N.; Gold, D. V.; Wegener, W. A.; Goldenberg, D. M.

fiu authors

publication date

  • 2011

published in

Digital Object Identifier (DOI)


  • 29


  • 4

research area

  • Oncology  Web of Science Research Area